Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Thus, the future of a cure for HBV lies in triple combination therapies with concerted action on replication inhibition, antigen reduction, and immune stimulation. This book reviews the mechanisms and pathogenesis of HBV, as well as discusses current and potential future treatments.
Edited by:
Luis Rodrigo Imprint: IntechOpen Country of Publication: United Kingdom Dimensions:
Height: 260mm,
Width: 180mm,
Spine: 10mm
Weight: 408g ISBN:9781803550060 ISBN 10: 1803550066 Pages: 126 Publication Date:23 June 2022 Audience:
Professional and scholarly
,
Undergraduate
Format:Hardback Publisher's Status: Active